- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Plasma-derived Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2026, from $ xx million in 2020.Specially this report presents the global revenue market share of key companies in Plasma-derived Therapies business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma-derived Therapies market by product type, application, key manufacturers and key regions and countries.
Segmentation by product type:
Albumin
Immunoglobulin
Factor VIII
Others
Segmentation by Application:
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma-derived Therapies Market Size 2021-2026
2.1.2 Plasma-derived Therapies Market Size CAGR by Region
2.2 Plasma-derived Therapies Segment by Type
2.2.1 Albumin
2.2.2 Immunoglobulin
2.2.3 Factor VIII
2.2.4 Others
2.3 Plasma-derived Therapies Market Size by Type
2.3.1 Global Plasma-derived Therapies Market Size Market Share by Type (2021-2026)
2.3.2 Global Plasma-derived Therapies Market Size Growth Rate by Type (2021-2026)
2.4 Plasma-derived Therapies Segment by Application
2.4.1 Hemophilia
2.4.2 Primary Immunodeficiencies (PIDs)
2.4.3 Idiopathic Thrombocytopenic Purpura (ITP)
2.4.4 COVID-19
2.4.5 Others
2.5 Plasma-derived Therapies Market Size by Application
2.5.1 Global Plasma-derived Therapies Market Size Market Share by Application (2021-2026)
2.5.2 Global Plasma-derived Therapies Market Size Growth Rate by Application (2021-2026)
3 Plasma-derived Therapies Key Players
3.1 Date of Key Players Enter into Plasma-derived Therapies
3.2 Key Players Plasma-derived Therapies Product Offered
3.3 Key Players Plasma-derived Therapies Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Plasma-derived Therapies Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Plasma-derived Therapies by Regions
4.1 Plasma-derived Therapies Market Size by Regions (2021-2026)
4.2 Americas Plasma-derived Therapies Market Size Growth (2021-2026)
4.3 APAC Plasma-derived Therapies Market Size Growth (2021-2026)
4.4 Europe Plasma-derived Therapies Market Size Growth (2021-2026)
5 Americas
5.1 Americas Plasma-derived Therapies Market Size by Countries (2021-2026)
5.2 Americas Plasma-derived Therapies Market Size by Type (2021-2026)
5.3 Americas Plasma-derived Therapies Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma-derived Therapies Market Size by Regions
6.2 APAC Plasma-derived Therapies Market Size by Type (2021-2026)
6.3 APAC Plasma-derived Therapies Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Plasma-derived Therapies by Countries (2021-2026)
7.2 Europe Plasma-derived Therapies Market Size by Type (2021-2026)
7.3 Europe Plasma-derived Therapies Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in Plasma-derived Therapies
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 CSL Behring LLC
10.1.1 CSL Behring LLC Company Details
10.1.2 CSL Behring LLC Plasma-derived Therapies Product Offered
10.1.3 CSL Behring LLC Plasma-derived Therapies Market Size (2021 VS 2026)
10.1.4 CSL Behring LLC Main Business Overview
10.1.5 CSL Behring LLC News
10.2 Shire
10.2.1 Shire Company Details
10.2.2 Shire Plasma-derived Therapies Product Offered
10.2.3 Shire Plasma-derived Therapies Market Size (2021 VS 2026)
10.2.4 Shire Main Business Overview
10.2.5 Shire News
10.3 Bayer
10.3.1 Bayer Company Details
10.3.2 Bayer Plasma-derived Therapies Product Offered
10.3.3 Bayer Plasma-derived Therapies Market Size (2021 VS 2026)
10.3.4 Bayer Main Business Overview
10.3.5 Bayer News
10.4 Kedrion
10.4.1 Kedrion Company Details
10.4.2 Kedrion Plasma-derived Therapies Product Offered
10.4.3 Kedrion Plasma-derived Therapies Market Size (2021 VS 2026)
10.4.4 Kedrion Main Business Overview
10.4.5 Kedrion News
10.5 Takeda
10.5.1 Takeda Company Details
10.5.2 Takeda Plasma-derived Therapies Product Offered
10.5.3 Takeda Plasma-derived Therapies Market Size (2021 VS 2026)
10.5.4 Takeda Main Business Overview
10.5.5 Takeda News
10.6 Biotest
10.6.1 Biotest Company Details
10.6.2 Biotest Plasma-derived Therapies Product Offered
10.6.3 Biotest Plasma-derived Therapies Market Size (2021 VS 2026)
10.6.4 Biotest Main Business Overview
10.6.5 Biotest News
10.7 Octaparma
10.7.1 Octaparma Company Details
10.7.2 Octaparma Plasma-derived Therapies Product Offered
10.7.3 Octaparma Plasma-derived Therapies Market Size (2021 VS 2026)
10.7.4 Octaparma Main Business Overview
10.7.5 Octaparma News
10.8 Bio Products Laboratory (BPL)
10.8.1 Bio Products Laboratory (BPL) Company Details
10.8.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Offered
10.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2021 VS 2026)
10.8.4 Bio Products Laboratory (BPL) Main Business Overview
10.8.5 Bio Products Laboratory (BPL) News
10.9 LFB
10.9.1 LFB Company Details
10.9.2 LFB Plasma-derived Therapies Product Offered
10.9.3 LFB Plasma-derived Therapies Market Size (2021 VS 2026)
10.9.4 LFB Main Business Overview
10.9.5 LFB News
10.10 Grifols
10.10.1 Grifols Company Details
10.10.2 Grifols Plasma-derived Therapies Product Offered
10.10.3 Grifols Plasma-derived Therapies Market Size (2021 VS 2026)
10.10.4 Grifols Main Business Overview
10.10.5 Grifols News
11 Research Findings and Conclusion
List of Tables
Table 1. Plasma-derived Therapies Market Size CAGR by Region (2021-2026) ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Factor VIII
Table 5. Major Players of Others
Table 6. Global Plasma-derived Therapies Market Size by Type (2021-2026) ($ Millions)
Table 7. Global Plasma-derived Therapies Market Size Market Share by Type (2021-2026)
Table 8. Global Plasma-derived Therapies Market Size by Application (2021-2026) ($ Millions)
Table 9. Global Plasma-derived Therapies Market Size Market Share by Application (2021-2026)
Table 10. Date of Global Key Players Enter into Plasma-derived Therapies Market
Table 11. Global Key Players Plasma-derived Therapies Product Offered
Table 12. Key Players Plasma-derived Therapies Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players Plasma-derived Therapies Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. Plasma-derived Therapies New Product/Technology Launches
Table 18. Plasma-derived Therapies Industry Partnerships, Agreements, and Collaborations
Table 19. Plasma-derived Therapies Industry Mergers and Acquisitions
Table 20. Global Plasma-derived Therapies Market Size by Regions 2021-2026 ($ Millions)
Table 21. Global Plasma-derived Therapies Market Size Market Share by Regions 2021-2026
Table 22. Americas Plasma-derived Therapies Market Size by Countries (2021-2026) ($ Millions)
Table 23. Americas Plasma-derived Therapies Market Size Market Share by Countries (2021-2026)
Table 24. Americas Plasma-derived Therapies Market Size by Type (2021-2026) ($ Millions)
Table 25. Americas Plasma-derived Therapies Market Size Market Share by Type (2021-2026)
Table 26. Americas Plasma-derived Therapies Market Size by Application (2021-2026) ($ Millions)
Table 27. Americas Plasma-derived Therapies Market Size Market Share by Application (2021-2026)
Table 28. APAC Plasma-derived Therapies Market Size by Regions (2021-2026) ($ Millions)
Table 29. APAC Plasma-derived Therapies Market Size Market Share by Regions (2021-2026)
Table 30. APAC Plasma-derived Therapies Market Size by Type (2021-2026) ($ Millions)
Table 31. APAC Plasma-derived Therapies Market Size Market Share by Type (2021-2026)
Table 32. APAC Plasma-derived Therapies Market Size by Application (2021-2026) ($ Millions)
Table 33. APAC Plasma-derived Therapies Market Size Market Share by Application (2021-2026)
Table 34. Europe Plasma-derived Therapies Market Size by Countries (2021-2026) ($ Millions)
Table 35. Europe Plasma-derived Therapies Market Size Market Share by Countries (2021-2026)
Table 36. Europe Plasma-derived Therapies Market Size by Type (2021-2026) ($ Millions)
Table 37. Europe Plasma-derived Therapies Market Size Market Share by Type (2021-2026)
Table 38. Europe Plasma-derived Therapies Market Size by Application (2021-2026) ($ Millions)
Table 39. Europe Plasma-derived Therapies Market Size Market Share by Application (2021-2026)
Table 40. Key and Potential Regions of Plasma-derived Therapies
Table 41. Key Application and Potential Industries of Plasma-derived Therapies
Table 42. Key Challenges of Plasma-derived Therapies
Table 43. Key Trends of Plasma-derived Therapies
Table 44. Company A Company Details
Table 45. Companies Invested by Company A
Table 46. Company A Key Development and Market Layout
Table 47. Company B Company Details
Table 48. Companies Invested by Company B
Table 49. Company B Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. Company C Company Details
Table 54. Companies Invested by Company C
Table 55. Company C Key Development and Market Layout
Table 56. CSL Behring LLC Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. CSL Behring LLC Plasma-derived Therapies Market Size (2021 VS 2026)
Table 58. Shire Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Shire Plasma-derived Therapies Market Size (2021 VS 2026)
Table 60. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Bayer Plasma-derived Therapies Market Size (2021 VS 2026)
Table 62. Kedrion Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Kedrion Plasma-derived Therapies Market Size (2021 VS 2026)
Table 64. Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Takeda Plasma-derived Therapies Market Size (2021 VS 2026)
Table 66. Biotest Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Biotest Plasma-derived Therapies Market Size (2021 VS 2026)
Table 68. Octaparma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Octaparma Plasma-derived Therapies Market Size (2021 VS 2026)
Table 70. Bio Products Laboratory (BPL) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Bio Products Laboratory (BPL) Plasma-derived Therapies Market Size (2021 VS 2026)
Table 72. LFB Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. LFB Plasma-derived Therapies Market Size (2021 VS 2026)
Table 74. Grifols Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Grifols Plasma-derived Therapies Market Size (2021 VS 2026)
List of Figures
Figure 1. Picture of Plasma-derived Therapies
Figure 2. Plasma-derived Therapies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Therapies Market Size Growth Rate 2021-2026 ($ Millions)
Figure 7. Plasma-derived Therapies Market Size by Region (2021 & 2026) ($ millions)
Figure 8. Global Plasma-derived Therapies Market Size Market Share by Type (2021-2026)
Figure 9. Global Albumin Market Size Growth Rate
Figure 10. Global Immunoglobulin Market Size Growth Rate
Figure 11. Global Factor VIII Market Size Growth Rate
Figure 12. Global Others Market Size Growth Rate
Figure 13. Plasma-derived Therapies in Hemophilia
Figure 14. Global Plasma-derived Therapies Market: Hemophilia (2021-2026) ($ Millions)
Figure 15. Plasma-derived Therapies in Primary Immunodeficiencies (PIDs)
Figure 16. Global Plasma-derived Therapies Market: Primary Immunodeficiencies (PIDs) (2021-2026) ($ Millions)
Figure 17. Plasma-derived Therapies in Idiopathic Thrombocytopenic Purpura (ITP)
Figure 18. Global Plasma-derived Therapies Market: Idiopathic Thrombocytopenic Purpura (ITP) (2021-2026) ($ Millions)
Figure 19. Plasma-derived Therapies in COVID-19
Figure 20. Global Plasma-derived Therapies Market: COVID-19 (2021-2026) ($ Millions)
Figure 21. Plasma-derived Therapies in Others
Figure 22. Global Plasma-derived Therapies Market: Others (2021-2026) ($ Millions)
Figure 23. Global Plasma-derived Therapies Market Size Market Share by Application (2021-2026)
Figure 24. Global Plasma-derived Therapies Market Size in Hemophilia Growth Rate
Figure 25. Global Plasma-derived Therapies Market Size in Primary Immunodeficiencies (PIDs) Growth Rate
Figure 26. Global Plasma-derived Therapies Market Size in Idiopathic Thrombocytopenic Purpura (ITP) Growth Rate
Figure 27. Global Plasma-derived Therapies Market Size in COVID-19 Growth Rate
Figure 28. Global Plasma-derived Therapies Market Size in Others Growth Rate
Figure 29. Funding/Investment
Figure 30. Global Plasma-derived Therapies Market Size Market Share by Regions 2021-2026
Figure 31. Americas Plasma-derived Therapies Market Size 2021-2026 ($ Millions)
Figure 32. APAC Plasma-derived Therapies Market Size 2021-2026 ($ Millions)
Figure 33. Europe Plasma-derived Therapies Market Size 2021-2026 ($ Millions)
Figure 34. Americas Plasma-derived Therapies Market Size Market Share by Countries in 2020
Figure 35. Americas Plasma-derived Therapies Market Size Market Share by Type in 2020
Figure 36. Americas Plasma-derived Therapies Market Size Market Share by Application in 2020
Figure 37. United States Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 38. Canada Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 39. Mexico Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 40. Brazil Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 41. APAC Plasma-derived Therapies Market Size Market Share by Regions in 2020
Figure 42. APAC Plasma-derived Therapies Market Size Market Share by Type in 2020
Figure 43. APAC Plasma-derived Therapies Market Size Market Share by Application in 2020
Figure 44. China Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 45. Japan Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 46. Korea Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 47. Southeast Asia Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 48. India Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 49. Australia Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 50. Europe Plasma-derived Therapies Market Size Market Share by Countries in 2020
Figure 51. Europe Plasma-derived Therapies Market Size Market Share by Type in 2020
Figure 52. Europe Plasma-derived Therapies Market Size Market Share by Application in 2020
Figure 53. Germany Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 54. France Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 55. UK Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 56. Italy Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
Figure 57. Russia Plasma-derived Therapies Market Size Growth 2021-2026 ($ Millions)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
